Tearsheet

HCA Healthcare (HCA)


Market Price (2/15/2026): $540.29 | Market Cap: $122.5 Bil
Sector: Health Care | Industry: Health Care Facilities

HCA Healthcare (HCA)


Market Price (2/15/2026): $540.29
Market Cap: $122.5 Bil
Sector: Health Care
Industry: Health Care Facilities

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.1%, FCF Yield is 6.3%
Trading close to highs
Dist 52W High is 0.0%, Dist 3Y High is 0.0%
Key risks
HCA key risks include [1] multi-year payer mix pressure from Exchanges in 2026 and [2] Provider Tax pressure in 2028 and beyond.
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 17%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 10%, CFO LTM is 13 Bil, FCF LTM is 7.7 Bil
  
2 Low stock price volatility
Vol 12M is 28%
  
3 Megatrend and thematic drivers
Megatrends include Artificial Intelligence, Digital Health & Telemedicine, and Aging Population & Chronic Disease. Themes include AI in Healthcare Management, Show more.
  
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.1%, FCF Yield is 6.3%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 17%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 10%, CFO LTM is 13 Bil, FCF LTM is 7.7 Bil
2 Low stock price volatility
Vol 12M is 28%
3 Megatrend and thematic drivers
Megatrends include Artificial Intelligence, Digital Health & Telemedicine, and Aging Population & Chronic Disease. Themes include AI in Healthcare Management, Show more.
4 Trading close to highs
Dist 52W High is 0.0%, Dist 3Y High is 0.0%
5 Key risks
HCA key risks include [1] multi-year payer mix pressure from Exchanges in 2026 and [2] Provider Tax pressure in 2028 and beyond.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

HCA Healthcare (HCA) stock has gained about 20% since 10/31/2025 because of the following key factors:

1. Strong Fourth Quarter 2025 Earnings Beat. HCA Healthcare reported robust financial and operating results for the fourth quarter ended December 31, 2025, on January 27, 2026. Revenues increased 6.7% year-over-year to $19.513 billion, and diluted earnings per share (EPS) surged 44.6% to $8.14 per share, significantly surpassing analyst estimates of $7.37 to $7.53. Net income also grew by 30.6%. This strong performance was primarily driven by solid same-facility admissions growth of 2.4% and equivalent admissions growth of 2.5%, alongside a 2.9% increase in same-facility revenue per equivalent admission.

2. Optimistic 2026 Guidance and Outlook. The company provided a positive outlook for fiscal year 2026, projecting profit above Wall Street expectations. HCA Healthcare's guidance included anticipated 2026 revenues between $76.5 billion and $80 billion, adjusted EBITDA between $15.55 billion and $16.45 billion, and diluted EPS in the range of $29.10 to $31.50. This forward-looking guidance instilled confidence in investors regarding the company's sustained growth potential and its ability to manage various market and policy dynamics.

Show more

Stock Movement Drivers

Fundamental Drivers

The 17.7% change in HCA stock from 10/31/2025 to 2/14/2026 was primarily driven by a 7.2% change in the company's P/E Multiple.
(LTM values as of)103120252142026Change
Stock Price ($)459.00540.2917.7%
Change Contribution By: 
Total Revenues ($ Mil)74,37275,6001.7%
Net Income Margin (%)8.5%9.0%5.2%
P/E Multiple16.818.17.2%
Shares Outstanding (Mil)2332272.7%
Cumulative Contribution17.7%

LTM = Last Twelve Months as of date shown

Market Drivers

10/31/2025 to 2/14/2026
ReturnCorrelation
HCA17.7% 
Market (SPY)-0.0%-2.7%
Sector (XLV)9.3%2.5%

Fundamental Drivers

The 53.1% change in HCA stock from 7/31/2025 to 2/14/2026 was primarily driven by a 19.8% change in the company's P/E Multiple.
(LTM values as of)73120252142026Change
Stock Price ($)352.83540.2953.1%
Change Contribution By: 
Total Revenues ($ Mil)71,58575,6005.6%
Net Income Margin (%)8.1%9.0%11.2%
P/E Multiple15.118.119.8%
Shares Outstanding (Mil)2472278.9%
Cumulative Contribution53.1%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2025 to 2/14/2026
ReturnCorrelation
HCA53.1% 
Market (SPY)8.2%5.4%
Sector (XLV)21.4%12.8%

Fundamental Drivers

The 65.0% change in HCA stock from 1/31/2025 to 2/14/2026 was primarily driven by a 27.4% change in the company's P/E Multiple.
(LTM values as of)13120252142026Change
Stock Price ($)327.45540.2965.0%
Change Contribution By: 
Total Revenues ($ Mil)69,62175,6008.6%
Net Income Margin (%)8.5%9.0%5.4%
P/E Multiple14.218.127.4%
Shares Outstanding (Mil)25722713.2%
Cumulative Contribution65.0%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2025 to 2/14/2026
ReturnCorrelation
HCA65.0% 
Market (SPY)14.3%18.4%
Sector (XLV)8.8%26.6%

Fundamental Drivers

The 117.0% change in HCA stock from 1/31/2023 to 2/14/2026 was primarily driven by a 36.4% change in the company's P/E Multiple.
(LTM values as of)13120232142026Change
Stock Price ($)248.93540.29117.0%
Change Contribution By: 
Total Revenues ($ Mil)59,80075,60026.4%
Net Income Margin (%)9.0%9.0%-0.2%
P/E Multiple13.218.136.4%
Shares Outstanding (Mil)28622726.1%
Cumulative Contribution117.0%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2023 to 2/14/2026
ReturnCorrelation
HCA117.0% 
Market (SPY)74.0%25.8%
Sector (XLV)23.7%36.3%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
HCA Return58%-6%14%12%57%15%240%
Peers Return49%-26%13%17%14%8%80%
S&P 500 Return27%-19%24%23%16%-0%82%

Monthly Win Rates [3]
HCA Win Rate67%50%58%58%67%100% 
Peers Win Rate62%45%53%60%58%60% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
HCA Max Drawdown-5%-35%-7%0%-1%-1% 
Peers Max Drawdown-11%-49%-21%-11%-15%-8% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-1% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: THC, UHS, CYH, EHC, SGRY. See HCA Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/13/2026 (YTD)

How Low Can It Go

Unique KeyEventHCAS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-39.7%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven65.8%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven289 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-54.9%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven121.7%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven237 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-23.4%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven30.6%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven247 days120 days

Compare to THC, UHS, CYH, EHC, SGRY

In The Past

HCA Healthcare's stock fell -39.7% during the 2022 Inflation Shock from a high on 4/20/2022. A -39.7% loss requires a 65.8% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About HCA Healthcare (HCA)

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

AI Analysis | Feedback

Analogy 1: Marriott for hospitals

Analogy 2: The Hilton of healthcare facilities

AI Analysis | Feedback

  • Acute Care Hospital Services: Provides comprehensive medical, surgical, and emergency care within their network of hospitals.
  • Outpatient and Ambulatory Services: Encompasses a variety of non-hospital settings including freestanding emergency rooms, urgent care centers, surgical centers, imaging centers, and physician clinics.
  • Behavioral Health Services: Offers specialized treatment programs for mental health and substance use disorders.
  • Rehabilitation Services: Delivers physical, occupational, and speech therapy aimed at recovery and improving functional abilities.

AI Analysis | Feedback

HCA Healthcare (NYSE: HCA) primarily sells its healthcare services to individuals.

The major categories of customers (patients) it serves, based on their primary payer source, include:

  • Patients with Commercial Insurance: These individuals have healthcare coverage through private insurance companies. HCA Healthcare contracts with a wide range of commercial insurers (such as UnitedHealthcare, Aetna, Cigna, and Elevance Health) to provide medical services to their members.
  • Patients Covered by Government Programs: This category includes individuals whose healthcare costs are primarily financed by government-sponsored programs. Key examples are Medicare (serving those aged 65 and older, and certain younger people with disabilities), Medicaid (for low-income individuals and families), and TRICARE (for military personnel and their families).
  • Self-Pay Patients: These are individuals who are either uninsured or choose to pay for their medical services directly out-of-pocket, without the involvement of a third-party payer for the primary coverage.

AI Analysis | Feedback

  • McKesson Corporation (MCK)
  • Cardinal Health, Inc. (CAH)
  • Johnson & Johnson (JNJ)
  • Medtronic plc (MDT)
  • Baxter International Inc. (BAX)
  • Stryker Corporation (SYK)
  • GE HealthCare Technologies Inc. (GEHC)

AI Analysis | Feedback

Samuel N. Hazen, Chief Executive Officer

Samuel N. Hazen is the Chief Executive Officer of HCA Healthcare, a position he assumed on January 1, 2019. He is a veteran of HCA Healthcare, having served the company for over 40 years. Prior to his CEO appointment, Hazen was president and chief operating officer since 2016. He has held various senior leadership positions within HCA, including president of operations (2011-2015) and president of HCA Healthcare's Western Group (2001-2010), where he was also its chief financial officer. Hazen began his career in 1983 in Humana's Financial Management Specialist program and has served as chief financial officer for hospitals in Georgia and Las Vegas. He serves on the boards of the Nashville Health Care Council, the Federation of American Hospitals, and the HCA Healthcare Foundation.

William B. Rutherford, Executive Vice President and Chief Financial Officer

William B. Rutherford serves as Executive Vice President and Chief Financial Officer of HCA Healthcare. He is a long-standing member of the HCA team, having joined as a staff auditor in 1986. Rutherford's roles at HCA have included Director of Operations Support and Chief Financial Officer for the Georgia Division, and Chief Financial Officer for the Eastern Group (1996-2005). In 2005, Rutherford left HCA to start his own training and education company, which also led to work with several private equity ventures. He also served as Chief Operating Officer of Psychiatric Solutions, a behavioral health services provider, from January 2006 to June 2007. Rutherford rejoined HCA in December 2008 as Chief Financial Officer of the Outpatient Services Group and later served as Chief Operating Officer of the Clinical and Physician Services Group before his appointment as CFO. He is a Certified Public Accountant.

Jon M. Foster, Executive Vice President and Chief Operating Officer

Jon M. Foster is the Executive Vice President and Chief Operating Officer of HCA Healthcare, a role he assumed on January 1, 2023. A 22-year veteran of HCA Healthcare, he previously served as president of HCA Healthcare's American Group since 2011. Prior to that, he was president and CEO of St. David's HealthCare in Austin, Texas, and executive vice president of operations for the Baptist Health System of East Tennessee. His career in healthcare began in 1986 at the Methodist Healthcare System in Houston, Texas.

Joseph A. Sowell, III, Senior Vice President and Chief Development Officer

Joseph A. Sowell, III is the Senior Vice President and Chief Development Officer for HCA Healthcare, joining the company on December 1, 2009. In this role, he is responsible for all development functions and transactions, including mergers, acquisitions, divestitures, and real estate involving hospitals, outpatient centers, and physician practices. Before joining HCA, Sowell was a partner at Waller Lansden Dortch & Davis, where his practice focused on healthcare law, mergers and acquisitions, joint ventures, private equity financing, tax law, and general corporate law. He also co-managed the firm's Corporate and Commercial Transactions practice. Earlier in his career, Sowell served as the head of development and later as chief operating officer of a healthcare company focused on developing comprehensive ambulatory care centers.

Michael S. Cuffe, M.D., M.B.A., Executive Vice President and Chief Clinical Officer

Dr. Michael S. Cuffe is the Executive Vice President and Chief Clinical Officer of HCA Healthcare, a position he has held since January 1, 2022. In this role, he is responsible for the company's clinical agenda, including clinical quality, nursing, care transformation, clinical informatics, and he continues to lead physician services, which includes urgent care operations, graduate medical education, and laboratory services. Dr. Cuffe joined HCA Healthcare in October 2011 as president and CEO of Physician Services. Prior to his time at HCA, he served as vice president for Ambulatory Services and Chief Medical Officer for Duke University Health System. He also held various leadership roles within the Duke Clinical Research Institute and served as Vice Dean for the Duke University School of Medicine. Dr. Cuffe received his MD and MBA degrees from Duke University.

AI Analysis | Feedback

The key risks to HCA Healthcare (HCA) include changes in payer mix and regulatory pressures, labor shortages and rising labor costs, and cybersecurity incidents.

  1. Payer Mix and Regulatory Pressures: HCA Healthcare faces significant risks from potential multi-year payer mix pressures, specifically "Exchange pressure in 2026 and Provider Tax pressure in 2028 and beyond". Changes in healthcare policies and regulations, such as those affecting Medicare and Medicaid reimbursement rates and overall healthcare reform, could adversely impact the company's operations and profitability.
  2. Labor Shortages and Rising Labor Costs: The company faces operational risks due to competition for staffing, particularly experienced nurses and other healthcare professionals, which may lead to increased labor costs and affect operations. These "stubborn labor and supply cost pressures" are considered a challenge to HCA's financial performance.
  3. Cybersecurity Incidents: Cybersecurity incidents pose a significant risk to HCA Healthcare, with potential impacts on operations, patient safety, and legal liabilities. The company has implemented security measures but acknowledges vulnerabilities to advanced cyber threats.

AI Analysis | Feedback

The aggressive expansion and vertical integration of non-traditional healthcare providers represent a clear emerging threat. Large retail chains, technology giants, and payer-owned organizations are increasingly entering and expanding their footprint in healthcare delivery, particularly in primary care, urgent care, and specialized outpatient services.

Examples include:

  • Amazon: Acquired One Medical (primary care) and has been expanding its Amazon Pharmacy and virtual care offerings.
  • CVS Health: Beyond its MinuteClinic network, CVS has acquired Signify Health (home health and value-based care enabler) and has invested heavily in its HealthHUBs model, co-locating primary care with pharmacy services. They are also actively acquiring primary care groups like Oak Street Health.
  • Walgreens Boots Alliance: Has made significant investments in VillageMD, integrating primary care clinics within or adjacent to its pharmacies, and expanding into specialty pharmacy services with Shields Health Solutions.
  • UnitedHealth Group (Optum): As one of the largest employers of physicians in the U.S., Optum continues to acquire physician groups, urgent care centers, and specialty clinics, building out a comprehensive care delivery network often focused on value-based care models.
  • Walmart: Expanding its Walmart Health centers offering primary care, dental, behavioral health, and lab services.

These entities are establishing broad networks that compete directly with HCA's outpatient facilities and emergency rooms for patient volumes, especially for lower-acuity conditions and routine care. Their models often prioritize convenience, technology integration (telehealth, digital tools), and potentially lower costs, which can attract patients away from traditional hospital systems. This trend challenges HCA's traditional fee-for-service revenue streams and ability to capture patients across the care continuum.

AI Analysis | Feedback

HCA Healthcare (symbol: HCA) primarily operates in hospital and outpatient/ambulatory healthcare services in the United States and the United Kingdom. The addressable markets for their main products and services are as follows:

  • U.S. Hospital Services Market: The U.S. hospital services market was valued at approximately USD 2.48 trillion in 2024 and is projected to reach around USD 4.02 trillion by 2034, demonstrating a compound annual growth rate (CAGR) of 6.69% from 2025 to 2034. Another estimate placed the market at USD 2.32 trillion in 2023, with a projection to reach USD 3.79 trillion by 2033, growing at a CAGR of 4.85% from 2024 to 2033. In 2024, the U.S. hospital services market generated a revenue of USD 1.6014973 trillion and is expected to reach USD 2.0535116 trillion by 2030, with a CAGR of 4.2% from 2025 to 2030.

  • U.S. Outpatient/Ambulatory Services Market: The U.S. ambulatory services market size was estimated at USD 289.5 billion in 2023 and is projected to grow at a CAGR of 5.38% from 2024 to 2030. Outpatient volumes in the U.S. are expected to grow by 10.6% over the next five years.

  • Global Hospital Services Market: The global hospital services market size was estimated at USD 13.30 trillion in 2024 and is predicted to increase to approximately USD 24.17 trillion by 2034, expanding at a CAGR of 5.99% from 2025 to 2034.

  • Global Outpatient Care Market: The global outpatient care market size is expected to be worth around USD 150.7 billion by 2034, from USD 48.1 billion in 2024, growing at a CAGR of 12.1%.

AI Analysis | Feedback

HCA Healthcare (HCA) is expected to drive future revenue growth over the next 2-3 years through several key factors:

  1. Growth in Patient Volumes: HCA Healthcare consistently highlights broad-based volume growth across its markets and service lines as a primary revenue driver. This includes increases in same-facility admissions, equivalent admissions, and emergency room visits, reflecting strong demand for healthcare services, demographic trends, and the company's expanding service offerings. For instance, Q3 2025 saw 9.6% revenue growth driven by volume growth, and Q1 2024 reported a notable rise in same-facility admissions, emergency room visits, and outpatient surgeries.
  2. Favorable Payer Mix and Increased Patient Acuity: The company benefits from an improved payer mix, with a higher proportion of commercial volumes, and an increase in the acuity levels of its inpatient business. These factors lead to higher revenue per equivalent admission. For example, in Q1 2024, payer mix and acuity levels improved, with commercial volumes representing approximately 36% of equivalent admissions, up from 34% in the prior year.
  3. Strategic Network Development and Facility Expansion: HCA Healthcare is making significant capital investments to enhance its market position, expand its physical footprint, and increase capacity. This includes adding inpatient beds and developing new outpatient facilities, aiming to expand sites of care and improve access across its networks. HCA anticipates spending approximately $5 billion on capital expenditures for 2025, reflecting ongoing investment in infrastructure and services.
  4. Price Increases and Improved Reimbursement: HCA's revenue growth is also supported by higher reimbursement rates per equivalent admission. This indicates the company's ability to negotiate favorable pricing with payers and realize increased revenue from the services provided. In Q1 2024, same-facility revenue growth was a result of volume metrics coupled with 3.5% higher reimbursement per equivalent admission.

AI Analysis | Feedback

Capital Allocation Decisions of HCA Healthcare (HCA) (Last 3-5 Years)

Share Repurchases

  • HCA Healthcare's Board of Directors authorized an additional share repurchase program for up to $10 billion of the company's outstanding common stock, with no specified time limit.
  • In the third quarter of 2025, HCA repurchased 6.514 million shares of common stock at a cost of $2.498 billion.
  • During the fourth quarter of 2024, the company repurchased 4.739 million shares for $1.700 billion.

Outbound Investments

  • HCA Healthcare spent $635 million on acquisitions in 2023, which included $229 million for four hospital facilities in Texas and $406 million for non-hospital healthcare entities.
  • In the first quarter of 2023, HCA acquired 90% of Valesco in a joint venture with Envision Healthcare.
  • In the first quarter of 2025, HCA finalized the acquisitions of Catholic Medical Center in New Hampshire and Lehigh Medical Center in Florida for $227 million.

Capital Expenditures

  • HCA Healthcare's capital expenditures were approximately $4.7 billion in 2023.
  • Expected capital expenditures for 2024 are estimated to be around $5 billion.
  • For 2025, capital spending is projected to be between $5.0 billion and $5.2 billion, with a focus on upgrading facilities, technology, and service offerings, and expanding inpatient and outpatient capacity to meet growing demand. The company has approximately $6 billion worth of projects under development.

Better Bets vs. HCA Healthcare (HCA)

Latest Trefis Analyses

Trade Ideas

Select ideas related to HCA.

Unique Key

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

HCATHCUHSCYHEHCSGRYMedian
NameHCA Heal.Tenet He.Universa.Communit.Encompas.Surgery . 
Mkt Price540.29231.10234.813.42110.1415.46170.62
Mkt Cap122.520.314.80.511.12.012.9
Rev LTM75,60020,84616,99312,6445,7963,28814,818
Op Inc LTM11,9653,3471,9491,0821,0024991,516
FCF LTM7,6921,502950143403194676
FCF 3Y Avg6,0061,678773-74304168539
CFO LTM12,6362,4781,9484931,1082821,528
CFO 3Y Avg10,8602,5501,6413259522571,296

Growth & Margins

HCATHCUHSCYHEHCSGRYMedian
NameHCA Heal.Tenet He.Universa.Communit.Encompas.Surgery . 
Rev Chg LTM7.1%-0.6%10.2%0.7%11.1%10.1%8.6%
Rev Chg 3Y Avg7.9%3.1%8.7%0.9%10.9%10.4%8.3%
Rev Chg Q6.7%3.2%13.4%-0.1%9.4%6.6%6.7%
QoQ Delta Rev Chg LTM1.7%0.8%3.2%-0.0%2.2%1.6%1.6%
Op Mgn LTM15.8%16.1%11.5%8.6%17.3%15.2%15.5%
Op Mgn 3Y Avg15.2%13.8%9.8%7.3%16.1%14.7%14.2%
QoQ Delta Op Mgn LTM0.2%0.4%0.5%1.6%0.2%0.8%0.4%
CFO/Rev LTM16.7%11.9%11.5%3.9%19.1%8.6%11.7%
CFO/Rev 3Y Avg15.4%12.3%10.5%2.6%18.1%8.6%11.4%
FCF/Rev LTM10.2%7.2%5.6%1.1%6.9%5.9%6.4%
FCF/Rev 3Y Avg8.5%8.1%4.9%-0.6%5.8%5.6%5.7%

Valuation

HCATHCUHSCYHEHCSGRYMedian
NameHCA Heal.Tenet He.Universa.Communit.Encompas.Surgery . 
Mkt Cap122.520.314.80.511.12.012.9
P/S1.61.00.90.01.90.60.9
P/EBIT10.15.77.50.310.84.86.6
P/E18.115.010.81.420.5-11.512.9
P/CFO9.78.27.60.910.07.07.9
Total Yield6.1%6.7%9.7%71.9%5.5%-8.7%6.4%
Dividend Yield0.6%0.0%0.4%0.0%0.6%0.0%0.2%
FCF Yield 3Y Avg7.1%14.4%6.3%-18.4%3.4%6.5%6.4%
D/E0.40.60.324.60.22.00.5
Net D/E0.40.50.324.30.21.90.4

Returns

HCATHCUHSCYHEHCSGRYMedian
NameHCA Heal.Tenet He.Universa.Communit.Encompas.Surgery . 
1M Rtn11.7%14.8%15.0%2.4%7.1%-3.4%9.4%
3M Rtn14.5%19.8%4.4%4.9%-2.8%1.2%4.7%
6M Rtn37.0%34.3%31.8%25.3%-8.2%-32.2%28.5%
12M Rtn72.1%73.4%29.9%1.2%9.9%-40.2%19.9%
3Y Rtn113.7%274.5%60.8%-32.7%81.4%-56.6%71.1%
1M Excs Rtn14.1%19.7%19.2%6.5%11.2%1.6%12.7%
3M Excs Rtn14.5%15.8%3.1%0.2%-3.7%-2.3%1.7%
6M Excs Rtn32.0%28.4%25.9%19.6%-13.3%-37.0%22.8%
12M Excs Rtn61.3%70.2%18.6%-8.0%0.1%-52.0%9.3%
3Y Excs Rtn49.9%259.0%-2.0%-99.5%20.4%-119.6%9.2%

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Operating hospitals and related health care entities64,96860,23358,75251,53351,336
Total64,96860,23358,75251,53351,336


Price Behavior

Price Behavior
Market Price$540.29 
Market Cap ($ Bil)125.8 
First Trading Date03/10/2011 
Distance from 52W High0.0% 
   50 Days200 Days
DMA Price$483.92$423.18
DMA Trendupup
Distance from DMA11.6%27.7%
 3M1YR
Volatility31.0%27.6%
Downside Capture6.79-16.33
Upside Capture83.1741.38
Correlation (SPY)4.9%18.7%
HCA Betas & Captures as of 1/31/2026

 1M2M3M6M1Y3Y
Beta0.930.420.250.340.310.45
Up Beta-1.15-1.34-0.790.340.340.42
Down Beta0.02-0.09-0.340.150.370.36
Up Capture244%83%95%79%31%29%
Bmk +ve Days11223471142430
Stock +ve Days13223475150424
Down Capture204%135%67%-1%5%69%
Bmk -ve Days9192754109321
Stock -ve Days7192750101327

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with HCA
HCA74.6%27.7%1.99-
Sector ETF (XLV)9.6%17.4%0.3726.2%
Equity (SPY)14.0%19.4%0.5519.0%
Gold (GLD)74.3%25.3%2.17-5.1%
Commodities (DBC)7.0%16.7%0.242.6%
Real Estate (VNQ)7.9%16.6%0.2826.3%
Bitcoin (BTCUSD)-29.8%44.9%-0.65-9.0%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with HCA
HCA25.8%29.4%0.81-
Sector ETF (XLV)8.0%14.5%0.3745.3%
Equity (SPY)13.3%17.0%0.6240.1%
Gold (GLD)22.1%17.0%1.066.4%
Commodities (DBC)10.5%18.9%0.449.8%
Real Estate (VNQ)5.2%18.8%0.1842.8%
Bitcoin (BTCUSD)8.3%57.2%0.376.5%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with HCA
HCA23.7%32.4%0.74-
Sector ETF (XLV)11.2%16.5%0.5650.8%
Equity (SPY)15.6%17.9%0.7550.7%
Gold (GLD)15.3%15.6%0.822.0%
Commodities (DBC)8.1%17.6%0.3821.9%
Real Estate (VNQ)6.4%20.7%0.2750.0%
Bitcoin (BTCUSD)67.9%66.7%1.0710.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date1302026
Short Interest: Shares Quantity4.1 Mil
Short Interest: % Change Since 11520265.4%
Average Daily Volume1.3 Mil
Days-to-Cover Short Interest3.1 days
Basic Shares Quantity226.8 Mil
Short % of Basic Shares1.8%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
1/27/20267.1%  
10/24/20251.6%6.1%11.6%
7/25/2025-2.1%3.7%18.6%
4/25/2025-4.0%0.5%10.3%
1/24/2025-3.8%2.8%-1.8%
10/25/2024-8.9%-10.1%-18.5%
7/23/20244.5%10.2%15.3%
4/26/2024-2.4%-1.7%1.5%
...
SUMMARY STATS   
# Positive111816
# Negative1468
Median Positive4.5%4.3%9.6%
Median Negative-3.9%-5.9%-7.0%
Max Positive14.4%15.7%21.7%
Max Negative-21.8%-18.7%-24.0%

SEC Filings

Expand for More
Report DateFiling DateFiling
12/31/202502/10/202610-K
09/30/202510/30/202510-Q
06/30/202508/04/202510-Q
03/31/202505/01/202510-Q
12/31/202402/14/202510-K
09/30/202410/31/202410-Q
06/30/202407/29/202410-Q
03/31/202405/02/202410-Q
12/31/202302/16/202410-K
09/30/202310/26/202310-Q
06/30/202308/02/202310-Q
03/31/202304/27/202310-Q
12/31/202202/17/202310-K
09/30/202211/01/202210-Q
06/30/202208/01/202210-Q
03/31/202205/03/202210-Q

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1McAlevey, Michael REVP & Chief Legal & Admin Off.DirectSell11052025473.793,8921,843,9911,652,106Form
2Cuffe, Michael SEVP and Chief Clinical OfficerDirectSell9082025418.843,8361,606,67013,194,675Form
3Foster, Jon MEVP and COODirectSell5152025369.3215,6985,797,6614,670,481Form
4Bank, Of America Corp /de/ See FootnotesBuy328202527.97670  Form
5Bank, Of America Corp /de/ See FootnotesSell328202521.90477  Form